tiprankstipranks

Augmedix downgraded to Market Perform from Outperform at William Blair

William Blair downgraded Augmedix to Market Perform from Outperform after the company entered into a definitive agreement to be acquired by Commure for $2.35 per share in cash.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue